Literature DB >> 18200594

Genome-wide significance for dense SNP and resequencing data.

Clive J Hoggart1, Taane G Clark, Maria De Iorio, John C Whittaker, David J Balding.   

Abstract

The problem of multiple testing is an important aspect of genome-wide association studies, and will become more important as marker densities increase. The problem has been tackled with permutation and false discovery rate procedures and with Bayes factors, but each approach faces difficulties that we briefly review. In the current context of multiple studies on different genotyping platforms, we argue for the use of truly genome-wide significance thresholds, based on all polymorphisms whether or not typed in the study. We approximate genome-wide significance thresholds in contemporary West African, East Asian and European populations by simulating sequence data, based on all polymorphisms as well as for a range of single nucleotide polymorphism (SNP) selection criteria. Overall we find that significance thresholds vary by a factor of >20 over the SNP selection criteria and statistical tests that we consider and can be highly dependent on sample size. We compare our results for sequence data to those derived by the HapMap Consortium and find notable differences which may be due to the small sample sizes used in the HapMap estimate.

Mesh:

Year:  2008        PMID: 18200594     DOI: 10.1002/gepi.20292

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  99 in total

1.  Replication in genome-wide association studies.

Authors:  Peter Kraft; Eleftheria Zeggini; John P A Ioannidis
Journal:  Stat Sci       Date:  2009-11-01       Impact factor: 2.901

2.  Evaluating de novo locus-disease discoveries in GWAS using the signal-to-noise ratio.

Authors:  Xia Jiang; M Michael Barmada; Michael J Becich
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

3.  Mapping rare and common causal alleles for complex human diseases.

Authors:  Soumya Raychaudhuri
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

4.  Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies.

Authors:  Konstantinos C M Siontis; Nikolaos A Patsopoulos; John P A Ioannidis
Journal:  Eur J Hum Genet       Date:  2010-03-17       Impact factor: 4.246

Review 5.  Genome-wide significant associations for variants with minor allele frequency of 5% or less--an overview: A HuGE review.

Authors:  Orestis A Panagiotou; Evangelos Evangelou; John P A Ioannidis
Journal:  Am J Epidemiol       Date:  2010-09-28       Impact factor: 4.897

Review 6.  A compendium of genome-wide associations for cancer: critical synopsis and reappraisal.

Authors:  John P A Ioannidis; Peter Castaldi; Evangelos Evangelou
Journal:  J Natl Cancer Inst       Date:  2010-05-26       Impact factor: 13.506

Review 7.  A guide on gene prioritization in studies of psychiatric disorders.

Authors:  Sven Stringer; Kim C Cerrone; Wim van den Brink; Julia F van den Berg; Damiaan Denys; Rene S Kahn; Eske M Derks
Journal:  Int J Methods Psychiatr Res       Date:  2015-07-31       Impact factor: 4.035

Review 8.  Validating, augmenting and refining genome-wide association signals.

Authors:  John P A Ioannidis; Gilles Thomas; Mark J Daly
Journal:  Nat Rev Genet       Date:  2009-05       Impact factor: 53.242

9.  Genetic research in schizophrenia: new tools and future perspectives.

Authors:  Lars Bertram
Journal:  Schizophr Bull       Date:  2008-07-21       Impact factor: 9.306

10.  A simple and accurate method to determine genomewide significance for association tests in sequencing studies.

Authors:  Dan-Yu Lin
Journal:  Genet Epidemiol       Date:  2019-01-08       Impact factor: 2.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.